Who Owns Travere Therapeutics Stock?
NASDAQ: TVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:45 AM ET
Ownership breakdown
- Held by institutions
- 115.18%
- Institutions (% of float)
- 115.99%
- Held by insiders
- 0.69%
- Institutional holders
- 436
- Institutions 99.3%
- Insiders 0.7%
- Public and other 0.0%
Who owns Travere Therapeutics stock?
Institutional investors own about 115.2% of Travere Therapeutics's shares, spread across 436 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.69% of TVTX.
The largest institutional holders are Jupiter Topco LLC (12.01%), Blackrock Inc. (8.51%) and FMR, LLC (7.53%). Together, the top 10 institutions control 54.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their TVTX positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TVTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jupiter Topco LLC | 11.32M | 12.01% | +100.0% |
| Blackrock Inc. | 8.02M | 8.51% | +2.9% |
| FMR, LLC | 7.10M | 7.53% | -35.3% |
| Bank of America Corporation | 4.57M | 4.85% | +239.6% |
| State Street Corporation | 4.26M | 4.52% | -14.2% |
| Vanguard Capital Management LLC | 4.11M | 4.36% | +1.6% |
| Perceptive Advisors Llc | 3.75M | 3.98% | -9.4% |
| Nomura Asset Management International Inc | 2.81M | 2.98% | -14.0% |
| Adage Capital Partners GP L.L.C. | 2.57M | 2.73% | +163.0% |
| Geode Capital Management, LLC | 2.37M | 2.52% | +0.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TVTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.95M | 3.13% |
| iShares Trust-iShares Russell 2000 ETF | 2.28M | 2.42% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.24M | 2.38% |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 2.09M | 2.21% |
| Vanguard Explorer Fund | 1.43M | 1.52% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 1.41M | 1.50% |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 1.12M | 1.19% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07M | 1.13% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 977.01K | 1.04% |
| iShares Trust-iShares Russell 2000 Growth ETF | 837.99K | 0.89% |
Frequently asked questions
Who is the largest shareholder of Travere Therapeutics?
Jupiter Topco LLC is the largest institutional shareholder of TVTX, owning 12.01% of shares outstanding (11.32M shares) as of its latest 13F filing.
What percentage of Travere Therapeutics is owned by institutions?
Institutions own about 115.2% of TVTX shares and 116.0% of the public float.
How much of Travere Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.69% of TVTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.